{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:21:29Z","timestamp":1772900489041,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03509-z","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T03:02:54Z","timestamp":1733194974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-CdtB and anti-vinculin antibodies to diagnose irritable bowel syndrome in inflammatory bowel disease patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Luisa Leite","family":"Barros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian M.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Freitas Cardoso","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"de Sousa Carlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ad\u00e9rson Omar Mour\u00e3o Cintra","family":"Dami\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto Queiroz","family":"Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"1","key":"3509_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Chien Ng S, Kotze PG, et al. Crohn\u2019s disease Nat Rev Dis Primers. 2020;6(1):22.","journal-title":"Crohn's disease Nat Rev Dis Primers"},{"issue":"1","key":"3509_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis Nat Rev Dis Primers. 2020;6(1):74.","journal-title":"Ulcerative colitis Nat Rev Dis Primers"},{"issue":"1","key":"3509_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izz104","volume":"26","author":"KT Park","year":"2020","unstructured":"Park KT, Ehrlich OG, Allen JI, et al. The cost of inflammatory bowel disease: An initiative from the Crohn\u2019s & Colitis Foundation. Inflamm Bowel Dis. 2020;26(1):1\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"3509_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","volume":"94","author":"GP Ramos","year":"2019","unstructured":"Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94(1):155\u201365.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"3509_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cgh.2019.06.030","volume":"18","author":"PG Kotze","year":"2020","unstructured":"Kotze PG, Underwood FE, Dami\u00e3o AOMC, et al. Progression of Inflammatory bowel diseases throughout latin America and the caribbean: a systematic review. Clin Gastroenterol Hepatol. 2020;18(2):304\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"3509_CR6","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570\u201383.","journal-title":"Gastroenterology"},{"issue":"12","key":"3509_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","volume":"5","author":"KM Fairbrass","year":"2020","unstructured":"Fairbrass KM, Costantino SJ, Gracie DJ, et al. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(12):1053\u201362.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"3509_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jama.2020.22532","volume":"325","author":"M Camilleri","year":"2021","unstructured":"Camilleri M. Diagnosis and treatment of irritable bowel syndrome: a review. JAMA. 2021;325(9):865\u201377.","journal-title":"JAMA"},{"issue":"10","key":"3509_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrgastro.2016.141","volume":"13","author":"R Spiller","year":"2016","unstructured":"Spiller R, Major G. IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol. 2016;13(10):613\u201321.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"3509_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/gutjnl-2012-304066","volume":"63","author":"M Vivinus-Nebot","year":"2014","unstructured":"Vivinus-Nebot M, Frin-Mathy G, Bzioueche H, et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 2014;63(5):744\u201352.","journal-title":"Gut"},{"key":"3509_CR11","doi-asserted-by":"crossref","unstructured":"Lacy BE, Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017;6(11):99.","DOI":"10.3390\/jcm6110099"},{"issue":"1","key":"3509_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5056\/jnm16135","volume":"23","author":"JH Kim","year":"2017","unstructured":"Kim JH, Lin E, Pimentel M. Biomarkers of irritable bowel syndrome. J Neurogastroenterol Motil. 2017;23(1):20\u20136.","journal-title":"J Neurogastroenterol Motil"},{"issue":"5","key":"3509_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126438","volume":"10","author":"M Pimentel","year":"2015","unstructured":"Pimentel M, Morales W, Rezaie A, et al. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects. PLoS ONE. 2015;10(5): e0126438.","journal-title":"PLoS ONE"},{"issue":"11","key":"3509_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11): e012799.","journal-title":"BMJ Open"},{"issue":"8167","key":"3509_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM. A simple index of Crohn\u2019s-disease activity. Lancet. 1980;1(8167):514.","journal-title":"Lancet"},{"issue":"12","key":"3509_CR16","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","volume":"14","author":"JD Lewis","year":"2008","unstructured":"Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14(12):1660\u20136.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"3509_CR17","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1007\/s10620-019-05684-6","volume":"64","author":"W Morales","year":"2019","unstructured":"Morales W, Rezaie A, Barlow G, et al. Second-generation biomarker testing for irritable bowel syndrome using plasma anti-CdtB and anti-vinculin levels. Dig Dis Sci. 2019;64(11):3115\u201321.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"3509_CR18","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/ajg.2012.260","volume":"107","author":"SJ Halpin","year":"2012","unstructured":"Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(10):1474\u201382.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"3509_CR19","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/gut.2006.099978","volume":"56","author":"S Vermeire","year":"2007","unstructured":"Vermeire S, Noman M, Van Assche G, et al. Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn\u2019s disease. Gut. 2007;56(9):1226\u201331.","journal-title":"Gut"},{"key":"3509_CR20","doi-asserted-by":"crossref","unstructured":"Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017;152(5):1042\u201354 e1.","DOI":"10.1053\/j.gastro.2016.12.039"},{"issue":"10","key":"3509_CR21","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.14309\/ajg.0000000000000408","volume":"114","author":"EJ Scallan Walter","year":"2019","unstructured":"Scallan Walter EJ, Crim SM, Bruce BB, et al. Postinfectious irritable bowel syndrome after campylobacter infection. Am J Gastroenterol. 2019;114(10):1649\u201356.","journal-title":"Am J Gastroenterol"},{"key":"3509_CR22","doi-asserted-by":"crossref","unstructured":"do Nascimento Veras H, Medeiros P, Ribeiro SA, et al. Campylobacter jejuni virulence genes and immune-inflammatory biomarkers association with growth impairment in children from Northeastern Brazil. Eur J Clin Microbiol Infect Dis. 2018;37(10):2011\u201320.","DOI":"10.1007\/s10096-018-3337-0"},{"issue":"5","key":"3509_CR23","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s10620-014-3435-5","volume":"60","author":"M Pimentel","year":"2015","unstructured":"Pimentel M, Morales W, Pokkunuri V, et al. Autoimmunity links vinculin to the pathophysiology of chronic functional bowel changes following campylobacter jejuni infection in a rat model. Dig Dis Sci. 2015;60(5):1195\u2013205.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"3509_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2307\/3283419","volume":"80","author":"EM Narcisi","year":"1994","unstructured":"Narcisi EM, Paulin JJ, Fechheimer M. Presence and localization of vinculin in Giardia. J Parasitol. 1994;80(3):468\u201373.","journal-title":"J Parasitol"},{"issue":"10","key":"3509_CR25","doi-asserted-by":"publisher","first-page":"e0006005","DOI":"10.1371\/journal.pntd.0006005","volume":"11","author":"CH Coelho","year":"2017","unstructured":"Coelho CH, Durigan M, Leal DAG, et al. Giardiasis as a neglected disease in Brazil: Systematic review of 20 years of publications. PLoS Negl Trop Dis. 2017;11(10):e0006005.","journal-title":"PLoS Negl Trop Dis"},{"key":"3509_CR26","doi-asserted-by":"crossref","unstructured":"Schmulson M, Balbuena R, Corona de Law C. Clinical experience with the use of anti-CdtB and anti-vinculin antibodies in patients with diarrhea in Mexico. Rev Gastroenterol Mex. 2016;81(4):236\u20139.","DOI":"10.1016\/j.rgmxen.2016.07.002"},{"issue":"7","key":"3509_CR27","doi-asserted-by":"publisher","first-page":"e00064","DOI":"10.14309\/ctg.0000000000000064","volume":"10","author":"NJ Talley","year":"2019","unstructured":"Talley NJ, Holtmann G, Walker MM, et al. Circulating anti-cytolethal distending toxin B and anti-vinculin antibodies as biomarkers in community and healthcare populations with functional dyspepsia and irritable bowel syndrome. Clin Transl Gastroenterol. 2019;10(7):e00064.","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"3509_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2018.07.011","volume":"156","author":"G Barbara","year":"2019","unstructured":"Barbara G, Grover M, Bercik P, et al. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology. 2019;156(1):46-58 e7.","journal-title":"Gastroenterology."},{"issue":"3","key":"3509_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/gut.51.3.410","volume":"51","author":"KR Neal","year":"2002","unstructured":"Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002;51(3):410\u20133.","journal-title":"Gut"},{"issue":"5","key":"3509_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/gut.2009.202234","volume":"59","author":"JK Marshall","year":"2010","unstructured":"Marshall JK, Thabane M, Garg AX, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59(5):605\u201311.","journal-title":"Gut"},{"issue":"4","key":"3509_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5056\/jnm.2012.18.4.434","volume":"18","author":"V Pokkunuri","year":"2012","unstructured":"Pokkunuri V, Pimentel M, Morales W, et al. Role of cytolethal distending toxin in altered stool form and bowel phenotypes in a rat model of post-infectious irritable bowel syndrome. J Neurogastroenterol Motil. 2012;18(4):434\u201342.","journal-title":"J Neurogastroenterol Motil"},{"issue":"3","key":"3509_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10620-020-06109-5","volume":"65","author":"M Pimentel","year":"2020","unstructured":"Pimentel M, Lembo A. Microbiome and its role in irritable bowel syndrome. Dig Dis Sci. 2020;65(3):829\u201339.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"3509_CR33","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.clinthera.2016.05.003","volume":"38","author":"M Pimentel","year":"2016","unstructured":"Pimentel M, Purdy C, Magar R, et al. A predictive model to estimate cost savings of a novel diagnostic blood panel for diagnosis of diarrhea-predominant irritable bowel syndrome. Clin Ther. 2016;38(7):1638-52 e9.","journal-title":"Clin Ther."}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03509-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03509-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03509-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T04:03:29Z","timestamp":1733198609000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03509-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3509"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03509-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3245673\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Review Board of Clinics Hospital, University of S\u00e3o Paulo School of Medicine. Written informed consent was obtained from patients before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}